1. Home
  2. JVA vs PMCB Comparison

JVA vs PMCB Comparison

Compare JVA & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coffee Holding Co. Inc.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$3.94

Market Cap

20.2M

ML Signal

HOLD

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.45

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
PMCB
Founded
1971
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.2M
6.3M
IPO Year
1997
2001

Fundamental Metrics

Financial Performance
Metric
JVA
PMCB
Price
$3.94
$0.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
69.1K
★ 321.9K
Earning Date
06-12-2026
03-17-2026
Dividend Yield
★ 1.71%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.68
N/A
Revenue
★ $90,655,294.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.76
★ N/A
Revenue Growth
★ 17.54
N/A
52 Week Low
$2.93
$0.33
52 Week High
$5.03
$1.51

Technical Indicators

Market Signals
Indicator
JVA
PMCB
Relative Strength Index (RSI) 55.38 41.32
Support Level $3.30 $0.33
Resistance Level $4.07 $0.77
Average True Range (ATR) 0.15 0.05
MACD -0.01 0.00
Stochastic Oscillator 63.01 58.23

Price Performance

Historical Comparison
JVA
PMCB

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

Share on Social Networks: